Inventor · disambiguated record
Philip M. Sher
Also filed as: SHER PHILIP · SHER PHILIP M · SHER PHILIP MICHAEL
40 granted patents·1 pending application·2,912 citations·filing 1987–2012
98Inventor score
Files withBRISTOL MYERS SQUIBB CO27SQUIBB & SONS INC10SHER PHILIP MICHAEL2EWING WILLIAM R1SHER PHILIP M1
Top patents by PatentIndex Score
41 records- 0198US6515117B2C-aryl glucoside SGLT2 inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Feb 4, 2003·372 cites·17 claims
- 0298US6414126B1C-aryl glucoside SGLT2 inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Jul 2, 2002·380 cites·30 claims
- 0398US5770615ACatecholamine surrogates useful as β3 agonistsBRISTOL MYERS SQUIBB CO·Filed 1997·Granted Jun 23, 1998·254 cites·23 claims
- 0498US5491134ASulfonic, phosphonic or phosphiniic acid β3 agonist derivativesBRISTOL MYERS SQUIBB CO·Filed 1994·Granted Feb 13, 1996·262 cites·14 claims
- 0597US6936590B2C-aryl glucoside SGLT2 inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Aug 30, 2005·133 cites·9 claims
- 0697US6683056B2O-aryl glucoside SGLT2 inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Jan 27, 2004·145 cites·26 claims
- 0797US5541204AAryloxypropanolamine β 3 adrenergic agonistsBRISTOL MYERS SQUIBB CO·Filed 1994·Granted Jul 30, 1996·269 cites·16 claims
- 0897US5488064ABenzo 1,3 dioxole derivativesBRISTOL MYERS SQUIBB CO·Filed 1994·Granted Jan 30, 1996·250 cites·18 claims
- 0997US5100889A7-oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic diseaseSQUIBB & SONS INC·Filed 1990·Granted Mar 31, 1992·88 cites·41 claims
- 1096US5776983ACatecholamine surrogates useful as β3 agonistsBRISTOL MYERS SQUIBB CO·Filed 1994·Granted Jul 7, 1998·300 cites·14 claims
- 1193US8204729B2Device for predicting and managing blood glucose by analyzing the effect of, and controlling, pharmacodynamic insulin equivalentsSHER PHILIP MICHAEL·Filed 2007·Granted Jun 19, 2012·110 cites·11 claims
- 1292US7517991B2N-sulfonylpiperidine cannabinoid receptor 1 antagonistsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Apr 14, 2009·11 cites·11 claims
- 1391US7365061B22-Amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Apr 29, 2008·12 cites·7 claims
- 1489US7670288B2Fluctuating blood glucose notification threshold profiles and methods of useSHER PHILIP M·Filed 2006·Granted Mar 2, 2010·82 cites·36 claims
- 1589US7098235B2Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compoundsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Aug 29, 2006·18 cites·11 claims
- 1687US7452892B2Triazolopyrimidine cannabinoid receptor 1 antagonistsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Nov 18, 2008·10 cites·3 claims
- 1786US7425550B2Lactam glycogen phosphorylase inhibitors and method of useBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Sep 16, 2008·5 cites·20 claims
- 1886US7057046B2Lactam glycogen phosphorylase inhibitors and method of useBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jun 6, 2006·16 cites·10 claims
- 1985US5153327A7-Oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic diseaseSQUIBB & SONS INC·Filed 1991·Granted Oct 6, 1992·26 cites·4 claims
- 2084US7378418B2Azabicyclic heterocycles as cannabinoid receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted May 27, 2008·24 cites·31 claims
- 2183US5321036AThiazole and oxazole-based β3 adrenergic receptor agonistsBRISTOL MYERS SQUIBB CO·Filed 1993·Granted Jun 14, 1994·24 cites·31 claims
- 2282US6436914B12-hydroxy-3—(4-hydroxy-3-sulfonamidophenyl)—propylamines useful as beta 3 adrenergic agonistsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Aug 20, 2002·12 cites·13 claims
- 2379US7223786B22-aminonaphthalene derivatives and related glycogen phosphorylase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted May 29, 2007·2 cites·7 claims
- 2476US7943658B2Indole indane amide compounds useful as CB2 agonists and methodBRISTOL MYERS SQUIBB CO·Filed 2008·Granted May 17, 2011·2 cites·14 claims
- 2576US5280034ABis-heterocyclic prostaglandin analogsSQUIBB & SONS INC·Filed 1991·Granted Jan 18, 1994·16 cites·14 claims
- 2676US5238951AHeterocyclic amido prostaglandin analogsSQUIBB & SONS INC·Filed 1992·Granted Aug 24, 1993·17 cites·20 claims
- 2775US7276608B2Tetrahydroquinoline derivatives as cannabinoid receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Oct 2, 2007·6 cites·4 claims
- 2873US5827868AProstaglandin analogsSQUIBB & SONS INC·Filed 1991·Granted Oct 27, 1998·30 cites·19 claims
- 2971US7572808B2Triazolopyridine cannabinoid receptor 1 antagonistsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Aug 11, 2009·1 cites·13 claims
- 3065US7816357B2Azabicyclic heterocycles as cannabinoid receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Oct 19, 2010·2 cites·24 claims
- 3163US5723489AAryloxypropanolamine beta 3 adrenergic agonistsBRISTOL MYERS SQUIBB CO·Filed 1996·Granted Mar 3, 1998·17 cites·16 claims
- 3257US4783473AGeminally substituted cyclic ether carboxylic acids, derivatives thereof, compositions containing same and method of useSQUIBB & SONS INC·Filed 1987·Granted Nov 8, 1988·7 cites·13 claims
- 3351US7214704B22-Amino-1-functionalized tetralin derivatives and related glycogen phosphorylase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted May 8, 2007·0 cites·7 claims
- 3445US7226942B22-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jun 5, 2007·0 cites·7 claims
- 3545US4975452AGeminally substituted thiaheterocyclic carboxylic acids and derivatives thereofSQUIBB & SONS INC·Filed 1989·Granted Dec 4, 1990·3 cites·27 claims
- 3644US5260449AMethod for preparing 7-oxabicycloheptyl substituted bromooxazole amide prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compoundsSQUIBB & SONS INC·Filed 1992·Granted Nov 9, 1993·2 cites·29 claims
- 3744US2010137699A1Fluctuating Blood Glucose Notification Threshold Profiles and Methods of UseSHER PHILIP MICHAEL·Filed 2010·Application pending·0 cites
- 3842US5290799A7-oxabicycloheptyl substituted heterocyclic thioamide prostaglandin analogs useful in the treatment of thrombotic and vasospastic diseaseSQUIBB & SONS INC·Filed 1990·Granted Mar 1, 1994·4 cites·25 claims
- 3937US8815909B2Diaminocyclohexane compounds and uses thereofEWING WILLIAM R·Filed 2012·Granted Aug 26, 2014·0 cites·6 claims
- 4032USH1737H7-oxabicycloheptane carboxylic acid prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compounds and method for preparing sameBRISTOL MYERS SQUIBB CO·Filed 1997·Granted Jun 2, 1998·0 cites·22 claims
- 4132US5106991AGeminally substituted thiaheterocyclic carboxylic acids and derivatives thereofSQUIBB & SONS INC·Filed 1990·Granted Apr 21, 1992·0 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →